000 | 01177 a2200325 4500 | ||
---|---|---|---|
005 | 20250513045629.0 | ||
264 | 0 | _c19950310 | |
008 | 199503s 0 0 eng d | ||
022 | _a0140-6736 | ||
024 | 7 |
_a10.1016/s0140-6736(95)90441-7 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChakos, M H | |
245 | 0 | 0 |
_aCaudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine. _h[electronic resource] |
260 |
_bLancet (London, England) _cFeb 1995 |
||
300 |
_a456-7 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Letter; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntipsychotic Agents _xtherapeutic use |
650 | 0 | 4 |
_aCaudate Nucleus _xdrug effects |
650 | 0 | 4 |
_aClozapine _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
700 | 1 | _aLieberman, J A | |
700 | 1 | _aAlvir, J | |
700 | 1 | _aBilder, R | |
700 | 1 | _aAshtari, M | |
773 | 0 |
_tLancet (London, England) _gvol. 345 _gno. 8947 _gp. 456-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(95)90441-7 _zAvailable from publisher's website |
999 |
_c7853314 _d7853314 |